Capstone Therapeutics to Hold Operating Update Conference Call
08. Mai 2013 09:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., May 8, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, May 15, 2013 at 4:30 pm EDT. The call may be...
Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results
14. März 2013 08:15 ET
|
Capstone Therapeutics
TEMPE, Ariz., March 14, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today will hold a conference call and webcast to provide an operating update and 2012 financial...
Capstone Therapeutics to Hold Operating Update Conference Call
07. März 2013 11:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., March 7, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, March 14, 2013 at 4:30 pm EDT. The call may be...
Apolipoprotein E Mimetic Peptide AEM-28 Granted Orphan Drug Designation for the Treatment of Homozygous Familial Hypercholesterolemia
06. Dezember 2012 12:10 ET
|
Capstone Therapeutics
TEMPE, Ariz., Dec. 6, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today announced that LipimetiX Development, LLC ("LipimetiX") has received notice from the US Food...
Capstone Therapeutics Will Provide an Operating Update and Announces Third Quarter 2012 Financial Results
08. November 2012 11:01 ET
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...
Capstone Therapeutics to Hold Quarterly Update Conference Call
02. November 2012 12:05 ET
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 2, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, November 8, 2012 at 4:30 pm EST. The call may...
Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call
03. August 2012 16:01 ET
|
Capstone Therapeutics
TEMPE, Ariz. and SUDBURY, Mass., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics Corp. (OTCQB:CAPS) and LipimetiX, LLC, a privately-held biopharmaceutical company, today announced that they...
Capstone Therapeutics Provides Operating Update and Announces 2011 Financial Results
21. März 2012 08:30 ET
|
Capstone Therapeutics
TEMPE, Ariz., March 21, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics Corp. (OTCQB:CAPS) (the "Company") provided an operating update and announced financial results for 2011.
OPERATING UPDATE
We...
Capstone Therapeutics Announces Operational Update
20. Januar 2012 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Jan. 20, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) (the "Company") announced today additional steps it has taken to preserve cash and move toward winding down...
Capstone Therapeutics Announces Plan to Preserve Cash During Ongoing Partnering Efforts
14. Oktober 2011 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") announced today its plan to preserve cash during ongoing discussions with potential partners...